Humana Inc HUM shares are trading higher by 2.37% to $451.19 Wednesday morning. Shares of healthcare stocks are trading higher in sympathy with Elevance Health, which reported better-than-expected second-quarter financial results and raised guidance.
Strong financial performance and an optimistic outlook for Elevance Health indicate the potential for growth and profitability. This positive sentiment can lead investors to have a more favorable perception of the overall healthcare sector, including companies like Humana.
What Happened?
Elevance Health has announced adjusted second-quarter EPS of $9.04, reflecting a 13.4% year-over-year increase and surpassing the consensus estimate of $8.80. Furthermore, the company experienced a 13% growth in revenue, reaching $43.67 billion, exceeding the projected figure of $41.50 billion.
This increase can be attributed to premium rate increases in the Health Benefits business, higher premium revenue resulting from membership growth in Medicaid and Medicare, as well as the expansion of pharmacy product revenue through the acquisition of BioPlus in Q1 2023 and the growth of external pharmacy members served by CarelonRx...Read More
According to data from Benzinga Pro, Humana has a 52-week high of $571.30 and a 52-week low of $423.29.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
